We are looking forward to the BSGCT (British Society for Gene & Cell Therapy) Annual Conference 2026 in Newcastle, United Kingdom, on 17–18 April 2026.

This leading UK event brings together scientists, clinicians, and industry innovators to explore the latest breakthroughs in gene and & cell therapy, —from translational research to early‑phase clinical development and emerging therapeutic platforms.

Representing Richmond Pharmacology:

  • Stephen Wilkinson, Business Development Manager

‍

Our Focus at the Conference

  • Advances in gene and & cell therapy development
  • Translational pathways from preclinical findings to first‑in‑human studies
  • Safety and regulatory considerations for next‑generation therapies
  • Biomarker‑driven approaches to early‑phase trials
  • Collaboration between academic groups, biotech innovators, and clinical researchers

Connect With Us

If you are attending the BSGCT Annual Conference 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

Find out more here: Annual Conference - BSGCT

‍

Latest news

The Future of Cardiometabolic Research: Five Questions Shaping the Next Decade

October 22, 2026
Cardiometabolic research is continually evolving beyond explanations centred on single causes of disease.
Read more

Upcoming Event

AASLD

05 - 09 November 2026
Richmond Pharmacology is excited to join the AASLD Emerging Topic Conference: Unified Frontiers in Liver Disease in Denver, USA, on 05– 09 November 2026.
View event